Clinical Challenges: Options for Triple-Class Refractory Myeloma
Patients with so-called triple-class refractory multiple myeloma have poor survival, substantial hospitalizations, and a clinically…
Browsing Tag
pomalidomide
FDA Warns of Increased Death Risk in Trial of New Myeloma Drug
The FDA issued a safety alert on the newly approved multiple myeloma drug melphalan flufenamide…